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Abstract.  Dystrophin, the protein product of the 
Duchenne muscular dystrophy (DMD) gene locus, is 
expressed on the muscle fiber surface. One key to fur- 
ther understanding of the cellular function of dystro- 
phin would be extended knowledge about its subcel- 
lular organization. We have shown that dystrophin 
molecules are not uniformly distributed over the hu- 
meri, rat, and mouse skeletal muscle fiber surface 
using three independent methods. Incubation of single- 
teased muscle fibers with antibodies to dystrophin re- 
vealed a network of denser transversal rings (costa- 
meres) and finer longitudinal interconnections. Double 
staining of longitudinal semithin cryosections for dys- 
trophin and oz-actinin showed spatial juxtaposition of 
the costameres to the Z bands. Where peripheral myo- 
nuclei precluded direct contact of dystrophin to the Z 
bands the organization of dystrophin was altered into 
lacunae harboring the myonucleus. These lacunae were 
surrounded by a dystrophin ring and covered by a more 
uniform dystrophin veil. Mechanical skinning of single- 
teased fibers revealed tighter mechanical connection of 
dystrophin to the plasma membrane than to the under- 
lying internal domain of the muscle fiber. The entire 
dystrophin network remained preserved in its structure 
on isolated muscle sarcolemma and identical in appear- 
ante to the pattern observed on teased fibers. There- 
fore, connection of defined areas of plasma membrane 
or its constituents such as ion channels to single sar- 
comeres might be a potential function exerted by dys- 
trophin alone or in conjunction with other submem- 
brane cytoskeletal proteins. 
YSTROPHIN, the protein product of the  Duchenne 
muscular dystrophy (DMD)  1  gene locus on chromo- 
some Xp21 is a rod like molecule with a potential 
capacity of self association (11, 18, 29). Extensive sequence 
homologies to its autosomal homologue 6q dystrophin-related 
protein (DRP) (21) as well as to spectrin and o~-actinin  sug- 
gested that these molecules may be members of a family of 
large structural proteins expressed in muscle tissue (18). In- 
dividuals  suffering from DMD show complete lack or vast 
reduction of dystrophin in muscle tissue, whereas those with 
the allellc milder disease form, Becket muscular dystrophy 
(BMD), express reduced  quantities of  a semifunctional  mole- 
cule (1, 10, 12, 27, 37). Lack of dystrophin expression also 
causes the myopathy in the animal model of the mdr mouse 
(4, 33). Previous immunohistochemical studies using anti- 
bodies to different portions of the dystrophin molecule have 
indicated that dystrophin  is localized at the plasma mem- 
brane in normal skeletal  muscle (3, 40).  Immanoelectron 
microscopic localization  revealed that the COOH-terminal 
end of dystrophin is localized at or within the plasma mem- 
brane (7) whereas the NH2 terminus and the rod portion of 
the molecule are part of the subsarcolemmal cytoskeleton 
(5, 7, 8, 39). Ultrastructural studies using immunogold sug- 
1. Abbreviation  used in this paper: DMD, Duchenne muscular dystrophy. 
gested a  regular distribution  with an average distance of 
~120 nm between neighboring  dystrophin molecules both 
on longitudinal and transversal  sections (7, 8). In an effort 
to define the subcellular distribution  of dystrophin more 
closely we have developed three independent  methods for di- 
rect visualization of the regional dystrophin distribution on 
the skeletal muscle fiber membrane. 
Materials and Methods 
Sources of 1Issue 
Human muscle specimens were obtained  from orthopedic  surgery of pa- 
tients not suffering from neuromuscular  diseases.  DMD muscle was ob- 
tained from diagnostic biopsies of patients as described (37). In particular, 
muscle tissue of a DMD patient who was deleted for exous 1 to 52 as well 
as for the muscle and brain promoter regions and the genomie probe 754 
was used as negative control for semithin sections (37). Murine (C57BF10/ 
sc/sn/him) and rat (Wistar) muscle specimens were obtained from hind limb 
muscles (tibialis anterior and extensor digitorum longns muscle). The cor- 
responding mdx (C57Bl/101mdrdmdx/him) mouse hind limb muscles served 
as negative controls. 
Antibodies 
The following antibodies to dystrophin were used: dys 1, dys 2, and dys 3 
(25, 26) (NOVOCASTRA Laboratories,  Nev,  r.astle upon Tyne, UK). For 
the purpose  of comparison  it is important  to note that mAb Dy8/6C5  is 
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sponds to mAb dys 1, and Dyl0/12B2 corresponds to mAb dys 3 (L. V. B. 
Nicholson, personal communication). Further antibodies to dystrophin 
used in the study were 9C2, 9(25 (30), l-2a,  10 kd, 60 kd, (11, 13, 14). 
mAbs to dystrophin were used on murine muscle, specimens were pre- 
treated with 5 % goat serum in PBS for 1 h to avoid  unspecific  background 
staining. Subsequently, the primary and secondary  antibody  solutions con- 
taiucd 1% goat serum, and the secondary  antibodies were anti-mouse IgG 
raised in goat (Amersham Buchler GmbH, Brannscbweig, Germany). For 
double staining mouse  monoclonal  or sheep  polyclonal  antibodies to dystro- 
phin were combined with rabbit polyclonal antibodies to c~-actinin (ICN 
Biomedicals, Costa Mesa, CA), using streptavidin Texas red (Amersham 
Buchler GmbH) as marker for dystrophin and streptavidin-FITC (Amer- 
sham  Buchler GmbH)  as marker for ct-actinin. As additional control  normal 
and DMD muscle fibers were stained with antibodies to Na-K-ATPase  and 
insulin-receptor (Amersham Buchler GmbH). 
Western Blotting 
Proteins from total muscle homogenates were resolved by SDS-PAGE on 
linear 4-20% gradient gels using a3.5% stacking gel and tank blotted onto 
nitrocellulose sheets as described (36, 37).  100 ~tg of protein were loaded 
per lane. Western blots were probed with the different antibodies as for im- 
munofluorescence but using peroxidase/diaminobenzidine  as detection sys- 
tem (36,  37).  The amount of myosin loaded per lane was controlled by 
Coomassie staining of the post blot gels. 
Single-teased  Muscle Fibers 
Single muscle fibers were teased in PBS solution in the presence of protease 
inhibitors (36)  either before or after fixation  in ethylacetimidate (Sigma 
Chemical GmbH, Deisenhofen, C-ermany) (0.3 M, 20 rain). Teased fibers 
were placed on gelatine-coated glass slides and stained for dystrophin as 
described (37). All tissue specimens, semithin sections as well as teased and 
skinned muscle fibers were observed and photographed on a photomicro- 
scope (HI RS; Carl Zeiss; Oberkochen, Germany) equipped with epifiuo- 
rescence.  For double label experiments nuclear DNA was stained by ethid- 
ium bromide (Sigma Chemical GmbH, Deisenhofen, Germany), (1:10,000 
vol/vol in PBS, 2 rain) and detected as orange-red signal by the Texas red 
filter, and as a yellowish  signal by the FITC  filter. 
Semithin Cryosections 
Muscle specimens were immediately fixed in ethylacetimidate (0.3 M, 40 
rain) and, for human muscle only, subsequently in 4% paraformaldehyde 
in PBS for 20 rain. Thereafter, specimens were dehydrated in sucrose (2.3 
M, 2 h, containing 20% wt/vol polyvinyl pyrolidone).  Semithin cryosec- 
tions of 900-nm thickness were cut in a RMC MT 6,000 Ultracut at -70~ 
placed on polylysine (Sigma Chemical CnnbH)-coated glass slides and im- 
mnnostained as single-teased  fibers (cf.  Fig.  1) (35). 
Mechanical Skinning of  Single Fibers 
Mechanical skinning of single muscle fibers was performed modifying a 
protocol by Moisescu (23).  Fixed or unfixed teased single fibers were kept 
in PBS solution containing  protease inhibitors and pinned on wax plates un- 
der a stereo preparation-microscope (WILD). Using sharpened super fine 
forceps (Biology No. 5, Dumont Montignez, Switzerland) the sarcolemma 
was mechanically removed and transferred on gelatine-coated  glass slides. 
Staining was performed as for single-teased  fibers. 
Results 
Antibodies 
For further characterization Western blots of  muscle homog- 
enates were probed with antibodies to dystrophin (dys 2 and 
dys 3) and ot-actinin (Fig.  1). The mAbs dys 2 and dys 3 de- 
tected dystrophin as a single band (dys 2) or doublet (dys 3) 
of  400 kD in normal human rectus femoris muscle but failed 
to detect a band of  comparable molecular weight or other im- 
munoreactive bands in quadriceps muscle from a DMD boy 
with a deletion of exons 1-52 or mdx tibialis anterior muscle, 
Figure 1. Three  parallel West- 
ern  blots  of skeletal  muscle 
homogenates  with  identical 
loading (A, B, C) were probed 
with mAbs dys 2  (A), mAbs 
dys 3 (B), and polyclonal anti- 
bodies to c~-actinin (C).  The 
amount of myosin loaded per 
lane was controlled by Coo- 
massie  staining  of  the  post 
blot gels and is shown for one 
gel in D.  Lanes were loaded 
as follows:  lane I, molecular 
weight markers (the small ar- 
rows in A and C indicate myo- 
sin,  a protein of 200 kD and 
phosphorylase (B), a protein 
of 97.4  kD);  lanes  2  and 5, 
normal human rectus femoris 
muscle; lane 3, quadriceps fe- 
moris  muscle  from a  DMD 
patient  with  a  deletion  of 
exons  1-52  of the dystrophin 
gene; lane 4, tibialis  anterior 
muscle from md.r mouse. (A) 
Dystrophin-specific  mAbs dys 
2 detected  dystrophin (arrow) 
as a single band of 400 kD in 
normal (lanes 2 and 5) but not 
DMD (lane 3) or mdx (lane 4) 
muscle.  A  single  cross-reac- 
tive band of 130 kD was pres- 
ent in normal, DMD and, more 
pronounced,  in m2/x muscle. 
(B) The mAb dys 3 detected 
dystrophin (arrow) as a doub- 
let with a more prominent upper and a less prominent lower band 
of 400 kD in normal muscle 0anes 2 and 5) but not in DMD (lane 
3) or mdx (lane 4) muscle.  A cross reactive  band of 130 kD was 
detected  by dys 3 in identical  position as by dys 2. (C) The poly- 
clonal antibodies  to c~-actinin detected a  single  band of 100 kD 
(arrow)  in normal (lanes 2 and 5), DMD (lane 3), and mdr (lane 
4) muscle. 1'4o  significant cross-reactions to other proteins were ob- 
served.  (D) Control of the myosin content of the 100 ~g of muscle 
homogenate loaded per lane.  The myosin content was slightly  re- 
duced in the mdx muscle specimen. 
as previously reported  (26,  35).  Both antibodies  showed a 
faint crossreactive band at 130 kD in normal and DMD mus- 
cle which was more pronounced in mdx muscle. The identity 
of this protein is as yet unknown. The polyclonal antibodies 
to ot-actinin detected a single band of 100 kD in normal hu- 
man rectus femoris muscle, dystrophin-deficient Duchenne 
muscle  and  in  muscle  from  the  dystrophin-deficient  mdx 
mouse (Fig.  1). 
Muscle Staining 
In a first approach normal human,  rat,  and mouse skeletal 
muscle specimens were carefully dissected immediately af- 
ter removing and single teased muscle fibers were stained for 
dystrophin using a panel of eight specific antibodies. All an- 
tibodies tested revealed an identical uneven distribution of 
dystrophin on the muscle fiber surface. As a rule,  the fiber 
was  covered by a  dystrophin  network  which  consisted  of 
more predominant rings, encircling the whole fiber perpen- 
The Journal of Cell Biology, Volume 119, 1992  1184 Figure 2. Organization of dys- 
trophin on normal human skel- 
etal muscle  fiber  surface.  A 
single  teased  fiber  of rectus 
femoris muscle (a and b) was 
labeled with mAb dys 2 anti- 
dystrophin  from  mouse  fol- 
lowed by biotinylated  goat anti- 
mouse antibodies and Texas  red 
streptavidin.  (a) On a single- 
teased fiber dystrophin staining 
pattern displayed periodic or- 
ganization in costameres run- 
ning transversal to the long axis 
of  the fiber (arrows)  and irregu- 
larly interspersed interconnec- 
fions of  lower intensity (arrow- 
head). Some intercormections 
showed longitudinal organiza- 
tion  (arrowhead),  and others 
seemed to run parallel to the 
costameres  for a certain  dis- 
tahoe (small arrows). (b) Dys- 
trophin staining revealed regu- 
larly organized costameres on 
a single-teased  muscle fiber sur- 
face. Some sarcolemmal areas 
showed lattice-like dystrophin 
organization (arrows). In addi- 
tion,  lacunae (asterisks) were 
surrounded by a dystrophin  ring 
and some were partially  cov- 
ered by a fine dystrophin veil 
(small arrows).  Bar,  10/zm. 
dicular  to its longitudinal  axis  and  at regular intervals of 
~1-2/zm (Fig. 2, a and b). In analogy to the similar riblike 
scaffold which has been observed for the subcellular organi- 
zation of vinculin, 3,-actin,  and spectrin in muscle tissue (6, 
28) these major components of the dystrophin lattice will 
subsequently be termed "costameres: Using the micrometer 
focus the dystrophin costameres could be followed surround- 
ing the muscle fiber in its entire circumference. The space 
between the dystrophin costameres was occupied by more 
delicate interconnections whose fine structure and orienta- 
tion appeared less regular and dependent on the state of con- 
traction of the fiber. In a more relaxed state the intercormec- 
tions frequently appeared as finer rings running parallel to 
the costameres whereas in other places they showed longitu- 
dinal orientation (Fig. 2, a  and b). Similar results were ob- 
tained  using  fixed and  unfixed  tissue  with  slightly  better 
structural preservation after mild fixation (not shown). Even 
distribution  without costameric organization was observed 
for Na-K-ATPase and insulin receptor on normal and DMD 
single-teased muscle fibers (not shown). 
Because the  complex organization of dystrophin with a 
distance of approx.  1-2 #m between the costameres on the 
fiber surface would not allow for any direct explanation by 
dystrophin dimers or tetramers (29) we sought to correlate 
the observed immunofluorescence pattern to the periodicity 
of the contractile apparatus. Double labeling of longitudinal 
semithin cryosections of human and mouse skeletal muscle 
with antibodies to dystrophin and ct-actinin revealed focal 
Straub et al.  Visualization of Dystrophin Network  1185 Figure  3.  Semithin  cryosec- 
tions from normal mouse tibi- 
alis anterior muscle were la- 
beled  with  polyclonal 60-kD 
anti-dystrophin antibodies fol- 
lowed by biotinylated donkey- 
anti-sheep antibodies and strep- 
tavidin  Texas  red  (a-c)  and, 
subsequently,  with polyclonal 
anti-c~-actinin antibodies from 
rabbit followed by biotinylated 
donkey-anti-rabbit antibodies 
and streptavidin FITC (a and 
b).  (a)  Double  exposure  for 
dystrophin  (Texas  red)  and 
a-actinin  (FITC,  green)  re- 
vealed one to one juxtaposition 
of  dystrophin  accumulations 
(arrows) and  Z  bands  (small 
arrows) along the entire fiber 
surface. (b) Single exposure of 
the same fiber for dystrophin 
(arrows) confirmed direct jux- 
taposition by excluding phase 
shift due to change of the fluo- 
rescence  filter.  The  Z  bands 
were  faintly  labeled  due  to 
cross-reaction  of  these  anti- 
dystrophin antibodies to c~-ac- 
tinin  (13) (small arrows).  (c) 
Semithin cryosection showing 
dystrophin costameres if areas 
of the sarcolemma were in the 
plane of section (arrows). Bar, 
10 ~m. 
concentration of dystrophin at the region where the projected 
end of the Z bands would link up with the plasma membrane 
(Fig.  3,  a  and  b).  This  finding  was  obtained  independent 
from the state of myofiber contraction,  so that sarcomeres of 
different lengths retained the juxtaposed dystrophin accumu- 
lation. This juxtaposition of the dystrophin costameres to the 
Z  bands  could  be reproduced  using  different  fixation pro- 
tocols and even when unfixed fresh frozen semithin sections 
were  stained  (not  shown).  The costameres  sometimes  ap- 
peared wedge shaped, and the space between the costameres 
was  frequently  occupied  by  irregular  dystrophin  fluores- 
cence of lower intensity, probably corresponding to the inter- 
connections  seen  in  single-teased  fiber  preparations.  In- 
terestingly,  polyclonal  antibodies  to  dystrophin  known  to 
cross  react  with  a  muscle-specific  ct-actinin  isoform  (13) 
confirmed the close spatial  relation of the  subsarcolemmal 
dystrophin accumulation to the projected connection of the 
Z bands to the plasma membrane (Fig.  3 b). If the plane of 
section happened to cut tangentially through the sarcolemma 
a  similar  dystrophin  network  was  observed  as  on  single- 
teased muscle fibers (Fig.  3  c). 
Because this close spatial relationship between the dystro- 
phin costameres and the Z bands suggested a functional con- 
nection between these two subcellular components we were 
curious to see what pattern of dystrophin organization would 
be found at sarcolemmal regions where peripheral  myonu- 
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clei were located between these two structures. Simultane- 
ous staining for dystrophin and nuclear DNA by ethidium 
bromide demonstrated interruption of  the regular dystrophin 
network by randomly interspersed lacunae which harbored 
myonuclei (Fig. 4, a and b). These lacunae appeared to be 
surrounded by a dystrophin ring into which the dystrophin 
costameres inserted at right angle. Frequently but not always 
the single lacuna was covered by a very fine, much less dis- 
tincfly organized dystrophin veil. Probably due to mechan- 
ical preparation  only fragments of dystrophin veils were 
retained in some lacunae and attached to the perilacunar dys- 
trophin ring, and other lacunae lacked this cover altogether 
(Fig. 2 b). Dystrophin-deficient human muscle from previ- 
ously characterized DMD patients (37)  as well as muscle 
from mdx mice (4, 33) served as a negative control for teased 
single muscle fibers and for semithin sections. There was 
complete lack of staining for all antibodies to dystrophin 
tested (not shown). 
Previous experiments using plebbing of sarcolemmal vesi- 
cles  had  suggested that  dystrophin was  more  tightly as- 
sociated with the plasma membrane than with the internal 
domain of skeletal muscle fibers (41). To test this hypothesis 
by using a mechanical technique without biochemical altera- 
tion  of membraneous  components  including the  subsar- 
colemmal  dystrophin  network  we  isolated  muscle  fiber 
membranes by mechanical skinning of single-teased fibers. 
If a  single-teased muscle fiber was skinned no detectable 
fluorescence signal of dystrophin was retained on the fiber 
surface, indicating that at least a substantial part of the sub- 
sarcolemmal cytoskeleton was mechanically more tightly 
bound to the sarcolemma than to internal structures of the 
muscle fiber. The mechanically isolated sarcolemma of nor- 
mal human, rat, and mouse muscle fibers again showed a 
dystrophin distribution with major transversal costameres 
which were interconnected by finer longitudinal bands, the 
network being identical in its fine topological organization 
to the one obtained by staining of single-teased fibers and by 
labeling of semithin sections (Fig. 5, a and b). Moreover, the 
dystrophin pattern on mechanically isolated sarcolemma was 
identical  for  NH2-terminal,  midrod  and  COOH-terminal 
antibodies to dystrophin.  Lacunae which had harbored a 
myonucleus  before skinning were detectable as holes with or 
without  surrounding  dystrophin rings  on  isolated  sarco- 
lemma (Fig. 5 a).  No dystrophin was detected on the sar- 
colemma of DMD control muscle, where the presence of the 
subsarcolemmal cytoskeleton was demonstrated by antibod- 
ies to spectrin- and dystrophin-related protein (not shown). 
Discussion 
So far,  immunoelectron microscopy had localized dystro- 
phin to the cytoplasmic face of  the sarcolemma (5, 8, 38, 39). 
If antibodies with specificity for different domains of dystro- 
phin were used, the COOH-terminal part of the molecule 
seemed to be localized closer to or even within the plasma 
membrane (8).  This morphological observation was in ac- 
cordance to the biochemical finding that dystrophin binds via 
its COOH-terminal domain to integral membrane glycopro- 
teins (9).  Immunocytocbemical detection of dystrophin on 
cryoscctions had shown a continuous outline of dystrophin 
both on longitudinal and transverse sections in a number of 
independent studies (1, 2, 37, 41). As a result, several hypo- 
thetical models of subeellular dystrophin distribution were 
based on the assumption that dystrophin was uniformly dis- 
tributed over the skeletal muscle fiber surface (10, 17, 32). 
In keeping with this concept, the observation that muscle 
from patients with the allelic milder form of BMD or of 
DMD carriers sometimes showed a regularly "dotted" im- 
munofluorescence  pattern was attributed to focal discontinu- 
ity of the cell-surface dystrophin distribution in the presence 
of a  semifunctional or  quantitatively reduced  dystrophin 
molecule (2, 24, 37). In contrast, all three preparation meth- 
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from  normal  human  rectus 
femoris  muscle  was  double 
stained for dystrophin (dys 2) 
and  nuclear  DNA  (ethidium 
bromide). (a) Costameric dys- 
trophin  organization (red)  is 
preserved. Lacunae are occu- 
pied by orange red fluorescent 
peripheral  myonuclei (a.~ter- 
isks). (b) The same fiber ana- 
lyzed by ~rc ~lter. Pmpber~ 
myonuclei  are  labeled  yel- 
lowish by ethidinm bromide 
fluorescence (aster/s~). Bar, 
10/~m. 
ods we used revealed a spatially organized dystrophin net- 
work on the muscle fiber surface with defined relation to the 
contractile apparatus. The regular "dotted" immunofluores- 
cence pattern of dystrophin on BMD or DMD carrier mus- 
cle, therefore, probably rather corresponded to the dystro- 
phin network as observed in our study and was laid open in 
BMD or DMD carrier muscle by the lower intensity of the 
fluorescence signal in the presence of  lower dystrophin abun- 
dance. Because isolated dystrophin molecules are capable of 
self association as dimers, trimers, or tetramers (29) but do 
not form more complex structures it seems likely that the 
higher organization of dystrophin within the submembrane 
cytoskeleton in form of a network is mediated by interaction 
with  other molecules  of the  submembrane  cytoskeleton. 
Such an association is still speculative at the moment. How- 
ever, a number of proteins such as vinculin, 7-actin, talin, 
and spectrin have been shown to constitute a submembrane 
cytoskeletal scaffold with costameric distribution as shown 
in this study for dystrophin (6, 28, 34). In connection with 
specific cell surface glycoproteins of similar distribution this 
scaffold is thought to play an important role in mechanical 
force transduction from the contractile apparatus to the ex- 
tracellular matrix (34). Interestingly, dystrophin has previ- 
ously been shown to colocalize with talin at focal adhesion 
sites in Xenopus muscle cultures (19) but no costameric dis- 
tribution was observed. The actin binding sites identified in 
the NH2-terminal sequence of dystrophin (20) further argue 
in  favor of a  complex interaction of the various  proteins 
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tion could also explain why in skeletal muscle of some DMD 
patients truncated d~,strophin molecules lacking the COOH 
terminus can become attached  to the submembrane cytoskel- 
eton (15, 31, 37) in the absence of the glycoprotein-binding 
COOH terminus of the molecule (9). 
The predominant dystrophin costameres were regularly 
found in close vicinity of the projected insertion of the Z 
bands into the sarcolemma. If this direct eormection of the 
Z bands to the sareolemma was prevented by the presence 
of  a peripheral myonucleus  the subsarcolemmal organization 
of dystrophin was changed which further supported the con- 
cept of a  functional importance of this juxtaposition. The 
perinuclear lacunae within the costameric dystrophin organ- 
Figure 5. Isolated sareolemma 
from normal human rectus fe- 
moris muscle was prepared as 
described  in  materials  and 
methods and  stained  with 
mAb to dystrophin as for sin- 
#e-teased fibers (ef. Fig. 2). 
(a) The predominant pattern 
of  dystrophin  distribution with 
costameres and finer intercon- 
neetions was retained (dys 2), 
including  a nuclear lacuna (as- 
terisk).  (b) Due to mechanical 
stretching of the  membrane 
some  longitudinal intercon- 
nections (arrows) lose contact 
to the  preserved costameres 
(dys 3). Bar, 10/~m. 
ization have not been observed in previous descriptions of 
submembrane proteins with costarneric organization (6, 28, 
34),  and longitudinal interconnections between the costa- 
meres were only mentioned for vinculin (28). However, we 
have evidence that at least for spectrin similar perinuclear 
lacunae and longitudinal interconnections between spectrin 
costameres are regularly found on human and mouse skel- 
etal muscle (Bittner, R. E., and T. Voit, manuscript in prep- 
aration). 
Tighter mechanical connection of dystrophin including its 
NH~-terminal domain (cf.  Fig.  5  b) to the plasma mem- 
brane  than  to  the  internal  muscle  fiber  structures  was 
directly proved by mechanical isolation of sarcolemma. Be- 
cause, on the other hand, the dystrophin costameres were al- 
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state of contraction it follows that during cycles of contrac- 
tion and relaxation defined areas of plasma membrane will 
correspond to defined sarcomeres.  Lack of dystrophin  has 
been shown to result in increased osmotic fragility of the 
muscle sarcolemma (22). Given these two independent ob- 
servations, one could hypothesize that dystrophin plays a role 
in connecting defined constituents of the plasma membrane 
such  as  dystrophin-associated  glycoproteins  to the  sarco- 
meres and, via these glycoproteins, even forms links to the 
extracellular matrix (16).  Such a hypothesis does not pre- 
clude more  specific interactions  of dystrophin  with other 
submembrane  proteins  or  with other proteins  within the 
plasma membrane (9,  10, 16). Further studies are needed to 
define if the molecular organization of dystrophin is the same 
within the costameres as within the longitudinal intercon- 
nections and especially, if any form of organiTation as a hex- 
agonal grid can be observed as was suggested by the presence 
of hinge regions within the dystrophin  molecule (17). 
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